Recognition and Publications
Selected publications
LaRocca T, Schwarzkopf M, Altman P, Zhang S, Gupta A, Gomes I, Alvin Z, Champion HC, Haddad G, Devi LA, Schecter AD, Tarzami ST. B2 adrenergic receptor in the heart is modulated by interactions with CXCR4 chemokine receptor. J Cardiovasc Pharmacol. 2010 Aug 18. [Epub ahead of print.]
Chen J, Chemaly E, Liang L, Kho C, Lee A, Park J, Altman P, Schecter AD, Hajjar RJ, Tarzami ST. Effects of CXCR4 gene transfer on cardiac function following ischemia reperfusion. Am J Pathol. 2010 Apr; 176(4):1705-15.
Lipsky R,* Potts EM,* Tarzami ST,* Puckerin AA, Stocks J, Schecter AD, Sobie EA, Akar FG, Diversé-Pierluissi MA. Activation of beta-2 adrenergic receptors induces spatial re-organization of Cav1.2 channel complexes. J Biol Chem. 2008 Jun 20; 283(25):17221-6.
Tarzami ST, Wang G, Li W, Green L, Singh JP. Enhancement of bone marrow-derived endothelial progenitor cell differentiation by PAR-1 activation. J Thromb Haemost. 2006 Mar; 4(3):656-63.
Tarzami ST, Calderon TM, Deguzman A, Lopez L, Kitsis RN, Berman JW. MCP-1/CCL-2 protects cardiac myocytes from hypoxia-induced apoptosis by a GI independent pathway. Biochem Biophys Res Commun. 2005 Oct 7; 335(4):1008-16.
Tarzami ST, Hsieh SS, Esterman MA, Singh JP. Staurosporine promotes endothelial cell assembly during in vitro angiogenesis by enhancing FAK phosphorylation. J Cardiovasc Pharmacol. 2005 Jan; 45(1):22-9.
Tarzami ST, Miao W, Mani K, Lopez L, Factor SM, Berman JW, Kitsis RN. Opposing effects mediated by the chemokine receptor, CXCR2, on myocardial ischemia-reperfusion injury: Recruitment of potentially damaging neutrophils and direct myocardial protection. Circulation. 2003 Nov 11; 108(19):2387-92.
Tarzami ST, Cheng R, Miao W, Kitsis RN, Berman JW. Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death. J Mol Cell Cardiol. 2002 Feb; 34(2):209-21.
Peer Review
Member of Associate Editorial Board: International Journal of Clinical and Experimental Medicine (IJCEM)
Reviewer: Journal of Cardiovascular Pharmacology, International Journal of Clinical and Experimental Pathology, FEBSLETTERS

